Erfanpoor, Saeed
Banihashemi, Seyed Reza
Mokhbaeralsafa, Ladan
Kalantari, Saeed
Es-haghi, Ali
Nofeli, Mojtaba
Rezaei Mokarram, Ali
Sadeghi, Fariba
Hajimoradi, Monireh
Razaz, Seyad Hossein
Taghdiri, Maryam
Lotfi, Mohsen
Khorasani, Akbar
Ansarifar, Akram
Masoumi, Safdar
Mohazzab, Arash
Filsoof, Sara
Mohseni, Vahideh
Shahsavan, Masoumeh
Gharavi, Niloufar
Setarehdan, Seyed Amin
Rabiee, Mohammad Hasan
Fallah Mehrabadi, Mohammad Hossein
Solaymani-Dodaran, Masoud
Article History
Received: 8 February 2023
Accepted: 12 February 2024
First Online: 20 February 2024
Declarations
:
: The study was approved by Iran National Committee for Ethics in Biomedical Research (the approval number was IR.NREC.1400.013) and performed in accordance with the Declaration of Helsinki and Good Clinical Practice and other relevant laws and regulations. Written informed consent signed and dated by the patients has been obtained. The trial protocol is registered at ExternalRef removed (IRCT20201214049709N4).
: Not applicable.
: As an academic CRO, the Iran University of medical sciences clinical trial center (IUMS-CTC) contributed to the conduct of the trial. SK contributed to the conduct of the trial as principal investigator. SRB, AE, MN, ARM, LM, FS, MHM, SHR, MT, ML, AK, and MHFM are Razi Vaccine and Serum Research Institute employees. SRB is the inventor of the RCP vaccine. The remaining authors are employees of IUMS.